A Markov model of fibrosis development in nonalcoholic fatty liver disease predicts fibrosis progression in clinical cohorts.

Autor: Knöchel, Jane1 (AUTHOR) jane.knochel@astrazeneca.com, Bergenholm, Linnéa2 (AUTHOR), Ibrahim, Eman3 (AUTHOR), Kechagias, Stergios4 (AUTHOR), Hansson, Sara5 (AUTHOR), Liljeblad, Mathias5 (AUTHOR), Nasr, Patrik4 (AUTHOR), Carlsson, Björn5 (AUTHOR), Ekstedt, Mattias4 (AUTHOR), Ueckert, Sebastian1 (AUTHOR)
Zdroj: CPT: Pharmacometrics & Systems Pharmacology. Dec2023, Vol. 12 Issue 12, p2038-2049. 12p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje